Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 237

1.

Impact of coronary artery disease in patients undergoing transcatheter aortic valve replacement: Insights from the FRANCE-2 registry.

Puymirat E, Didier R, Eltchaninoff H, Lung B, Collet JP, Himbert D, Durand E, Leguerrier A, Leprince P, Fajadet J, Teiger E, Chevreul K, Lièvre M, Tchetché D, Leclercq F, Chassaing S, Le Breton H, Donzeau-Gouge P, Lefèvre T, Carrié D, Gillard M, Blanchard D.

Clin Cardiol. 2017 Dec;40(12):1316-1322. doi: 10.1002/clc.22830. Epub 2017 Dec 16.

2.

Optical Coherence Tomography Characterization of Coronary Lithoplasty for Treatment of Calcified Lesions: First Description.

Ali ZA, Brinton TJ, Hill JM, Maehara A, Matsumura M, Karimi Galougahi K, Illindala U, Götberg M, Whitbourn R, Van Mieghem N, Meredith IT, Di Mario C, Fajadet J.

JACC Cardiovasc Imaging. 2017 Aug;10(8):897-906. doi: 10.1016/j.jcmg.2017.05.012.

PMID:
28797412
3.

Value-based healthcare, innovation and the future of interventional medicine: defining our place at the centre of the debate.

Heitner S, Spencer A, Fajadet J, Wijns W.

EuroIntervention. 2017 Aug 4;13(5):e508-e512. doi: 10.4244/EIJV13I5A80. No abstract available.

4.

Diagnostic Accuracy of Coronary CT Angiography for the Evaluation of Bioresorbable Vascular Scaffolds.

Collet C, Chevalier B, Cequier A, Fajadet J, Dominici M, Helqvist S, Van Boven AJ, Dudek D, McClean D, Almeida M, Piek JJ, Tenekecioglu E, Bartorelli A, Windecker S, Serruys PW, Onuma Y.

JACC Cardiovasc Imaging. 2017 Jul 13. pii: S1936-878X(17)30499-0. doi: 10.1016/j.jcmg.2017.04.013. [Epub ahead of print]

PMID:
28734923
5.

Arterial Remodeling After Bioresorbable Scaffolds and Metallic Stents.

Serruys PW, Katagiri Y, Sotomi Y, Zeng Y, Chevalier B, van der Schaaf RJ, Baumbach A, Smits P, van Mieghem NM, Bartorelli A, Barragan P, Gershlick A, Kornowski R, Macaya C, Ormiston J, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Windecker S, Byrne RA, Räber L, van Geuns RJ, Mintz GS, Onuma Y.

J Am Coll Cardiol. 2017 Jul 4;70(1):60-74. doi: 10.1016/j.jacc.2017.05.028.

PMID:
28662808
6.

Drug-coated versus bare-metal stents for elderly patients: A predefined sub-study of the LEADERS FREE trial.

Morice MC, Talwar S, Gaemperli O, Richardt G, Eberli F, Meredith I, Zaman A, Fajadet J, Copt S, Greene S, Urban P.

Int J Cardiol. 2017 Sep 15;243:110-115. doi: 10.1016/j.ijcard.2017.04.079. Epub 2017 Apr 25.

7.

Baseline characteristics and outcomes after transcatheter aortic-valve implantation in patients with or without previous balloon aortic valvuloplasty: Insights from the FRANCE 2 registry.

Bière L, Durfort A, Fouquet O, Hamel JF, Leprince P, Chevreul K, Prat A, Lievre M, Donzeau-Gouge P, Fajadet J, Teiger E, Eltchaninoff H, Iung B, Leguerrier A, Gilard M, Furber A.

Arch Cardiovasc Dis. 2017 Oct;110(10):534-542. doi: 10.1016/j.acvd.2016.12.012. Epub 2017 May 3.

PMID:
28479042
8.

Computing Methods for Composite Clinical Endpoints in Unprotected Left Main Coronary Artery Revascularization: A Post Hoc Analysis of the DELTA Registry.

Capodanno D, Gargiulo G, Buccheri S, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PE, Chakravarty T, Sheiban I, Mehran R, Naber C, Margey R, Agnihotri A, Marra S, Leon MB, Moses JW, Fajadet J, Lefèvre T, Morice MC, Erglis A, Alfieri O, Serruys PW, Colombo A, Tamburino C; DELTA Investigators.

JACC Cardiovasc Interv. 2016 Nov 28;9(22):2280-2288. doi: 10.1016/j.jcin.2016.08.025.

9.

Twelve-month results of a prospective, multicentre trial to assess the everolimus-eluting coronary stent system (PROMUS Element): the PLATINUM PLUS all-comers randomised trial.

Fajadet J, Neumann FJ, Hildick-Smith D, Petronio S, Zaman A, Spence M, Wöhrle J, Elhadad S, Roberts D, Hovasse T, Valdés M, Silber S.

EuroIntervention. 2017 Jan 20;12(13):1595-1604. doi: 10.4244/20150112-07.

10.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Artery Disease.

Stone GW, Sabik JF, Serruys PW, Simonton CA, Généreux P, Puskas J, Kandzari DE, Morice MC, Lembo N, Brown WM 3rd, Taggart DP, Banning A, Merkely B, Horkay F, Boonstra PW, van Boven AJ, Ungi I, Bogáts G, Mansour S, Noiseux N, Sabaté M, Pomar J, Hickey M, Gershlick A, Buszman P, Bochenek A, Schampaert E, Pagé P, Dressler O, Kosmidou I, Mehran R, Pocock SJ, Kappetein AP; EXCEL Trial Investigators.

N Engl J Med. 2016 Dec 8;375(23):2223-2235. Epub 2016 Oct 31.

11.

Late Outcomes of Transcatheter Aortic Valve Replacement in High-Risk Patients: The FRANCE-2 Registry.

Gilard M, Eltchaninoff H, Donzeau-Gouge P, Chevreul K, Fajadet J, Leprince P, Leguerrier A, Lievre M, Prat A, Teiger E, Lefevre T, Tchetche D, Carrié D, Himbert D, Albat B, Cribier A, Sudre A, Blanchard D, Rioufol G, Collet F, Houel R, Dos Santos P, Meneveau N, Ghostine S, Manigold T, Guyon P, Grisoli D, Le Breton H, Delpine S, Didier R, Favereau X, Souteyrand G, Ohlmann P, Doisy V, Grollier G, Gommeaux A, Claudel JP, Bourlon F, Bertrand B, Laskar M, Iung B; FRANCE 2 Investigators.

J Am Coll Cardiol. 2016 Oct 11;68(15):1637-1647. doi: 10.1016/j.jacc.2016.07.747.

12.

Transcatheter aortic valve implantation: there is still much to know.

Tamburino C, Fajadet J.

EuroIntervention. 2016 Sep 18;12(Y):Y21. doi: 10.4244/EIJV12SYA5. No abstract available.

13.

Magmaris preliminary recommendation upon commercial launch: a consensus from the expert panel on 14 April 2016.

Fajadet J, Haude M, Joner M, Koolen J, Lee M, Tölg R, Waksman R.

EuroIntervention. 2016 Sep 18;12(7):828-33. doi: 10.4244/EIJV12I7A137.

14.

Bioresorbable vascular scaffold fracture in the overlapping zone as cause of accelerated neoatherosclerosis and in-scaffold very-late thrombosis.

Mangiameli A, Fajadet J, Dumonteil N.

Int J Cardiovasc Imaging. 2017 Jan;33(1):1-3. doi: 10.1007/s10554-016-0967-0. Epub 2016 Aug 25. No abstract available.

PMID:
27562758
15.

Long-term clinical outcomes after percutaneous coronary intervention versus coronary artery bypass grafting for acute coronary syndrome from the DELTA registry: a multicentre registry evaluating percutaneous coronary intervention versus coronary artery bypass grafting for left main treatment.

Pyxaras SA, Hunziker L, Chieffo A, Meliga E, Latib A, Park SJ, Onuma Y, Capranzano P, Valgimigli M, Narbute I, Makkar RR, Palacios IF, Kim YH, Buszman PP, Chakravarty T, Sheiban I, Mehran R, Margey R, Agnihotri A, Marra S, Capodanno D, Leon MB, Moses JW, Fajadet J, Lefevre T, Morice MC, Erglis A, Tamburino C, Alfieri O, Serruys PW, Colombo A, Naber CK.

EuroIntervention. 2016 Aug 5;12(5):e623-31. doi: 10.4244/EIJV12I5A102.

16.

The Impact of Post-Procedural Asymmetry, Expansion, and Eccentricity of Bioresorbable Everolimus-Eluting Scaffold and Metallic Everolimus-Eluting Stent on Clinical Outcomes in the ABSORB II Trial.

Suwannasom P, Sotomi Y, Ishibashi Y, Cavalcante R, Albuquerque FN, Macaya C, Ormiston JA, Hill J, Lang IM, Egred M, Fajadet J, Lesiak M, Tijssen JG, Wykrzykowska JJ, de Winter RJ, Chevalier B, Serruys PW, Onuma Y.

JACC Cardiovasc Interv. 2016 Jun 27;9(12):1231-42. doi: 10.1016/j.jcin.2016.03.027. Epub 2016 Jun 1.

17.

Bioresorbable scaffolds for treatment of coronary bifurcation lesions: Critical appraisal and future perspectives.

Diletti R, Tchetche D, Barbato E, Latib A, Farah B, van Geuns RJ, Colombo A, Fajadet J, van Mieghem NM.

Catheter Cardiovasc Interv. 2016 Sep;88(3):397-406. doi: 10.1002/ccd.26454. Epub 2016 May 3. Review.

PMID:
27143281
18.

Prognostic value of new onset atrial fibrillation after transcatheter aortic valve implantation: A FRANCE 2 registry substudy.

Furuta A, Lellouche N, Mouillet G, Dhanjal T, Gilard M, Laskar M, Eltchaninoff H, Fajadet J, Iung B, Donzeau-Gouge P, Leprince P, Leuguerrier A, Prat A, Dubois-Rande JL, Teiger E.

Int J Cardiol. 2016 May 1;210:72-9. doi: 10.1016/j.ijcard.2016.02.073. Epub 2016 Feb 13.

PMID:
26930641
19.

Outcomes in Patients With Transcatheter Aortic Valve Replacement and Left Main Stenting: The TAVR-LM Registry.

Chakravarty T, Sharma R, Abramowitz Y, Kapadia S, Latib A, Jilaihawi H, Poddar KL, Giustino G, Ribeiro HB, Tchetche D, Monteil B, Testa L, Tarantini G, Facchin M, Lefèvre T, Lindman BR, Hariri B, Patel J, Takahashi N, Matar G, Mirocha J, Cheng W, Tuzcu ME, Sievert H, Rodés-Cabau J, Colombo A, Finkelstein A, Fajadet J, Makkar RR.

J Am Coll Cardiol. 2016 Mar 1;67(8):951-60. doi: 10.1016/j.jacc.2015.10.103.

20.

Prospective Multicenter Evaluation of the Direct Flow Medical Transcatheter Aortic Valve System: 12-Month Outcomes of the Evaluation of the Direct Flow Medical Percutaneous Aortic Valve 18F System for the Treatment of Patients With Severe Aortic Stenosis (DISCOVER) Study.

Lefèvre T, Colombo A, Tchétché D, Latib A, Klugmann S, Fajadet J, De Marco F, Maisano F, Bruschi G, Bijuklic K, Nava S, Weissman N, Low R, Thomas M, Young C, Redwood S, Mullen M, Yap J, Grube E, Nickenig G, Sinning JM, Hauptmann KE, Friedrich I, Lauterbach M, Schmoeckel M, Davidson C, Schofer J.

JACC Cardiovasc Interv. 2016 Jan 11;9(1):68-75. doi: 10.1016/j.jcin.2015.09.027.

Supplemental Content

Loading ...
Support Center